Regeneron Pharmaceuticals, Inc.
METHODS FOR TREATING ATOPIC DERMATITIS BY ADMINISTERING AN IL-4R INHIBITOR
Last updated:
Abstract:
The present invention provides methods for treating moderate-to-severe or severe atopic dermatitis (AD). The methods of the present invention comprise administering to a subject in need thereof one or more doses of an interleukin-4 receptor (IL-4R) inhibitor such as an anti-IL-4R antibody.
Status:
Application
Type:
Utility
Filling date:
10 May 2019
Issue date:
14 Nov 2019